154 related articles for article (PubMed ID: 19215015)
1. Maternal thyroid disease, thyroid medication use, and selected birth defects in the National Birth Defects Prevention Study.
Browne ML; Rasmussen SA; Hoyt AT; Waller DK; Druschel CM; Caton AR; Canfield MA; Lin AE; Carmichael SL; Romitti PA;
Birth Defects Res A Clin Mol Teratol; 2009 Jul; 85(7):621-8. PubMed ID: 19215015
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Medication Use and Birth Defects in the National Birth Defects Prevention Study.
Howley MM; Fisher SC; Van Zutphen AR; Waller DK; Carmichael SL; Browne ML;
Birth Defects Res; 2017 Nov; 109(18):1471-1481. PubMed ID: 28758357
[TBL] [Abstract][Full Text] [Related]
3. Maternal Thyroid Function, Use of Antithyroid Drugs in Early Pregnancy, and Birth Defects.
Andersen SL; Knøsgaard L; Olsen J; Vestergaard P; Andersen S
J Clin Endocrinol Metab; 2019 Dec; 104(12):6040-6048. PubMed ID: 31408173
[TBL] [Abstract][Full Text] [Related]
4. Maternal asthma medication use and the risk of selected birth defects.
Lin S; Munsie JP; Herdt-Losavio ML; Druschel CM; Campbell K; Browne ML; Romitti PA; Olney RS; Bell EM;
Pediatrics; 2012 Feb; 129(2):e317-24. PubMed ID: 22250027
[TBL] [Abstract][Full Text] [Related]
5. Maternal injuries during the periconceptional period and the risk of birth defects, National Birth Defects Prevention Study, 1997-2005.
Tinker SC; Reefhuis J; Dellinger AM; Jamieson DJ
Paediatr Perinat Epidemiol; 2011 Sep; 25(5):487-96. PubMed ID: 21819430
[TBL] [Abstract][Full Text] [Related]
6. Analysis of selected maternal exposures and non-syndromic atrioventricular septal defects in the National Birth Defects Prevention Study, 1997-2005.
Patel SS; Burns TL; Botto LD; Riehle-Colarusso TJ; Lin AE; Shaw GM; Romitti PA;
Am J Med Genet A; 2012 Oct; 158A(10):2447-55. PubMed ID: 22903798
[TBL] [Abstract][Full Text] [Related]
7. Maternal autoimmune disease and birth defects in the National Birth Defects Prevention Study.
Howley MM; Browne ML; Van Zutphen AR; Richardson SD; Blossom SJ; Broussard CS; Carmichael SL; Druschel CM;
Birth Defects Res A Clin Mol Teratol; 2016 Nov; 106(11):950-962. PubMed ID: 27891777
[TBL] [Abstract][Full Text] [Related]
8. Maternal exposure to methotrexate and birth defects: a population-based study.
Dawson AL; Riehle-Colarusso T; Reefhuis J; Arena JF;
Am J Med Genet A; 2014 Sep; 164A(9):2212-6. PubMed ID: 24898111
[TBL] [Abstract][Full Text] [Related]
9. Maternal caffeine intake and risk of selected birth defects in the National Birth Defects Prevention Study.
Browne ML; Hoyt AT; Feldkamp ML; Rasmussen SA; Marshall EG; Druschel CM; Romitti PA
Birth Defects Res A Clin Mol Teratol; 2011 Feb; 91(2):93-101. PubMed ID: 21254365
[TBL] [Abstract][Full Text] [Related]
10. Maternal intake of vitamin E and birth defects, national birth defects prevention study, 1997 to 2005.
Gilboa SM; Lee KA; Cogswell ME; Traven FK; Botto LD; Riehle-Colarusso T; Correa A; Boyle CA;
Birth Defects Res A Clin Mol Teratol; 2014 Sep; 100(9):647-57. PubMed ID: 24740457
[TBL] [Abstract][Full Text] [Related]
11. Maternal thyroid disease and risk of birth defects in offspring: a population-based case-control study.
Khoury MJ; Becerra JE; d'Almada PJ
Paediatr Perinat Epidemiol; 1989 Oct; 3(4):402-20. PubMed ID: 2479928
[TBL] [Abstract][Full Text] [Related]
12. Graves'-Basedow disease in pregnancy. New trends in the management and guidance to reduce the risk of birth defects caused by antithyroid drugs.
Laurberg P; Andersen SL
Nuklearmedizin; 2015; 54(3):106-11. PubMed ID: 26105719
[TBL] [Abstract][Full Text] [Related]
13. Specific birth defects in pregnancies of women with diabetes: National Birth Defects Prevention Study, 1997-2011.
Tinker SC; Gilboa SM; Moore CA; Waller DK; Simeone RM; Kim SY; Jamieson DJ; Botto LD; Reefhuis J;
Am J Obstet Gynecol; 2020 Feb; 222(2):176.e1-176.e11. PubMed ID: 31454511
[TBL] [Abstract][Full Text] [Related]
14. Maternal asthma medication use during pregnancy and risk of congenital heart defects.
Van Zutphen AR; Bell EM; Browne ML; Lin S; Lin AE; Druschel CM;
Birth Defects Res A Clin Mol Teratol; 2015 Nov; 103(11):951-61. PubMed ID: 26408052
[TBL] [Abstract][Full Text] [Related]
15. Maternal antihypertensive medication use and selected birth defects in the National Birth Defects Prevention Study.
Fisher SC; Van Zutphen AR; Werler MM; Romitti PA; Cunniff C; Browne ML;
Birth Defects Res; 2018 Nov; 110(19):1433-1442. PubMed ID: 30260586
[TBL] [Abstract][Full Text] [Related]
16. Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study.
van Gelder MM; Van Bennekom CM; Louik C; Werler MM; Roeleveld N; Mitchell AA
BJOG; 2015 Jun; 122(7):1002-9. PubMed ID: 25395267
[TBL] [Abstract][Full Text] [Related]
17. Maternal thyroid disease as a risk factor for craniosynostosis.
Rasmussen SA; Yazdy MM; Carmichael SL; Jamieson DJ; Canfield MA; Honein MA
Obstet Gynecol; 2007 Aug; 110(2 Pt 1):369-77. PubMed ID: 17666613
[TBL] [Abstract][Full Text] [Related]
18. Maternal butalbital use and selected defects in the national birth defects prevention study.
Browne ML; Van Zutphen AR; Botto LD; Louik C; Richardson S; Druschel CM
Headache; 2014 Jan; 54(1):54-66. PubMed ID: 24001268
[TBL] [Abstract][Full Text] [Related]
19. Associations between maternal periconceptional exposure to secondhand tobacco smoke and major birth defects.
Hoyt AT; Canfield MA; Romitti PA; Botto LD; Anderka MT; Krikov SV; Tarpey MK; Feldkamp ML
Am J Obstet Gynecol; 2016 Nov; 215(5):613.e1-613.e11. PubMed ID: 27443814
[TBL] [Abstract][Full Text] [Related]
20. Maternal exposures in the National Birth Defects Prevention Study: Time trends of selected exposures.
Dawson AL; Razzaghi H; Arth A; Canfield MA; Parker SE; Reefhuis J;
Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):703-12. PubMed ID: 25884728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
